CFR 21-600.81-2014
食品和药物. 第600部分:生物制品:总则. 第D子部分:总则. 第600.81节:分布报告.

Food and drugs. Part600:Biological products:general. SubpartD:Reporting of adverse experiences. Section600.81:Distribution reports.

非常抱歉，我们暂时无法提供预览，您可以试试： 免费下载 CFR 21-600.81-2014 前三页，或者稍后再访问。

您也可以尝试购买此标准，
点击右侧 “购买” 按钮开始采购（由第三方提供）。

注意： 点击下载后，生成下载文件时间比较长，请耐心等待......

标准号

CFR 21-600.81-2014

发布

2014年

发布单位

US-CFR-file

当前最新

CFR 21-600.81-2014

 

 

适用范围

The licensed manufacturer shall submit to the Center for Biologics Evaluation and Research or the Center for Drug Evaluation and Research (see mailing addresses in §600.2), information about the quantity of the product distributed under the biologics license, including the quantity distributed to distributors. The interval between distribution reports shall be 6 months. Upon written notice, FDA may require that the licensed manufacturer submit distribution reports under this section at times other than every 6 months.

CFR 21-600.81-2014相似标准

推荐

CFR 21-600.81-2014 中可能用到的仪器设备